Esther Chon
Department of Medical Sciences
Office: 4122
Clinical Interests
Canine oral melanoma
Translational research
Graduate Training
DVM - University of California, Davis, Davis, CA
Rotating Internship - Veterinary Medical & Surgical Group, Ventura, CA
Oncology Internship - Angell Animal Medical Center, Boston, MA
Clinical Trials Associate - Animal Clinical Investigation, LLC, Washington, DC
Medical Oncology Residency - University of Wisconsin-Madison, Madison, WI
Diplomate American College of Veterinary Internal Medicine (Oncology)
Recent Publications
Chon E, Thompson V, Schmid S, Stein TJ. Activation of the Canonical Wnt/β-catenin Signalling Pathway is Rare in Canine Malignant Melanoma Tissue and Cell Lines. J Comp Pathol. 2012 Aug 14 [Epub ahead of print].
Chon E, McCartan L, Kubicek LN, Vail DM. Safety Evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study. Vet Comp Oncol. 2012 Sep;10(3):184-93.
Takeuchi Y, Hashizume C, Chon EM, Momozawa Y, Masuda K, Kikusui T, Mori Y. Canine tyrosine hydroxylase (TH) gene and dopamine beta-hydroxylase (DBH) gene: their sequences, genetic polymorphisms, and diversities among five different dog breeds. J Vet Med Sci. 2005 Sep;67(9):861-7.